Strongbridge Biopharma plc

(SBBP) Trade

By |

Profile

Strongbridge Biopharma PLC is a biopharmaceutical company which focuses on the development, in-licensing, acquisition, and commercialization of various complementary products and product candidates that target rare diseases. The product portfolio of the group includes COR-003(levoketoconazole) and COR-005 (veldoreotide). COR-003 is a cortisol inhibitor which is used for the treatment of endogenous cushing's syndrome and COR-005 a novel somatostatin analog, which is used for the treatment of acromegaly. In addition, it is also developing BP-2002 (gene modified probiotic) which will be used for the treatment of Diabetes. Geographically, business activity of the firm is primarily functioned through the United States.

Contact Information

Website: www.strongbridgebio.com
Email: investors@strongbridgebio.com
Main Phone: +1 610 254-9200
Address: 900 Northbrook Drive
Address 2: Suite 200
State: PA
City / Town: Trevose
Country: USA
Postal Code: 19053

Issuer Information

Exchange: NGS
CEO: Matthew Pauls
Employees: 66
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 4.17 $ -0.1 (-2.34%)
Last Price 4.17 Change $ -0.1 Change % -2.34 Tick N/A
Bid 4.15 Bid Size 1,000.00 Ask 4.19 Ask Size 100.00
Open 4.42 High 4.42 Low 4.04 Prev Close 4.27
Last Trade Volume 108,492 52 Wk Hi 9.25 52 Wk Low 3.85
Market Cap 196.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 47,185,048.00 EPS (TTM) -2.08 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 14.75 14.75 14.75 14.75
Standard Deviation 2.5 2.5 2.5 2.5
Date of Most Recent Estimate 05/30/18 05/30/18 05/30/18 05/30/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1